De patienter, der får behandling med immunsuppressorer, inklusiv Advagraf, har en øget risiko for opportunistiske infektioner (bakteriel, fungal, viral og protozoal).
Patients treated with immunosuppressants, including Advagraf are at increased risk for opportunistic infections (bacterial, fungal, viral and protozoal).